Drug-Coated Balloons and Stents for Peripheral Vascular Disease

Drug-coated balloons and stents have revolutionized the treatment of peripheral vascular disease (PVD) by delivering localized therapies directly to the site of the lesion. These devices release anti-proliferative agents to inhibit restenosis, improving long-term patency rates compared to conventional treatments. The development of these technologies has enabled minimally invasive procedures that enhance patient outcomes and reduce the need for repeat interventions. Ongoing clinical trials are assessing the safety and efficacy of these devices in various patient populations. As their use expands, drug-coated balloons and stents will continue to play a crucial role in the management of PVD

    Related Conference of Drug-Coated Balloons and Stents for Peripheral Vascular Disease

    November 19-20, 2025

    7th World Heart Congress

    Tokyo, Japan
    November 24-25, 2025

    36th Annual Cardiologists Conference

    Barcelona, Spain
    November 27-28, 2025

    32nd World Heartcare Summit

    Paris, France
    January 12-13, 2026

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2026

    15th World Heart Congress

    Paris, France
    March 23-24, 2026

    41st World Cardiology Conference

    London, UK
    April 08-29, 2026

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 13-14, 2026

    9th World Heart and Brain Conference

    Tokyo, Japan
    May 14-15, 2026

    5th International Conference on Cardiology

    Rome, Italy
    May 21-22, 2026

    15th World Congress on Cardiology

    London, UK
    July 29-30, 2026

    30th World Cardiology Conference

    Paris, France

    Drug-Coated Balloons and Stents for Peripheral Vascular Disease Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in